Cargando…

RCANs regulate the convergent roles of NFATc1 in bone homeostasis

Activation of calcineurin-dependent nuclear factor of activated T cells c1 (NFATc1) is convergent for normal bone homeostasis. NFATc1 regulates both osteoclastogenesis and osteoblastogenesis. Here we investigated the roles of regulator of calcineurin (RCAN) genes in bone homeostasis. RCANs function...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jung Ha, Kim, Kabsun, Kim, Inyoung, Seong, Semun, Jeong, Byung-chul, Nam, Kwang-Il, Kim, Kyung Keun, Molkentin, Jeffery D., Kim, Nacksung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5137032/ https://www.ncbi.nlm.nih.gov/pubmed/27917924 http://dx.doi.org/10.1038/srep38526

Ejemplares similares

Tusc2/Fus1 regulates osteoclast differentiation through NF-κB and NFATc1
por: Kim, Inyoung, et al.
Publicado: (2017)

IRF2 enhances RANKL-induced osteoclast differentiation via regulating NF-κB/NFATc1 signaling
por: Kim, Inyoung, et al.
Publicado: (2021)

Adaptor protein CrkII negatively regulates osteoblast differentiation and function through JNK phosphorylation
por: Kim, Jung Ha, et al.
Publicado: (2019)

Alternative regulatory mechanism for the maintenance of bone homeostasis via STAT5-mediated regulation of the differentiation of BMSCs into adipocytes
por: Seong, Semun, et al.
Publicado: (2021)

STAT5 is a key transcription factor for IL-3-mediated inhibition of RANKL-induced osteoclastogenesis
por: Lee, Jongwon, et al.
Publicado: (2016)

Downregulation of Runx2 by 1,25-Dihydroxyvitamin D(3) Induces the Transdifferentiation of Osteoblasts to Adipocytes
por: Kim, Jung Ha, et al.
Publicado: (2016)

NRROS Negatively Regulates Osteoclast Differentiation by Inhibiting RANKL-Mediated NF-κB and Reactive Oxygen Species Pathways
por: Kim, Jung Ha, et al.
Publicado: (2015)

The IRF2BP2-KLF2 axis regulates osteoclast and osteoblast differentiation
por: Kim, Inyoung, et al.
Publicado: (2019)

Rev-erbα Negatively Regulates Osteoclast and Osteoblast Differentiation through p38 MAPK Signaling Pathway
por: Kim, Kabsun, et al.
Publicado: (2020)

The ATF3–OPG Axis Contributes to Bone Formation by Regulating the Differentiation of Osteoclasts, Osteoblasts, and Adipocytes
por: Kim, Jung Ha, et al.
Publicado: (2022)

Overexpression of Neurogenin 1 Negatively Regulates Osteoclast and Osteoblast Differentiation
por: Kim, Jung Ha, et al.
Publicado: (2022)

Bifunctional Role of CrkL during Bone Remodeling
por: Kim, Jung Ha, et al.
Publicado: (2021)

Transcription Factor Lmx1b Negatively Regulates Osteoblast Differentiation and Bone Formation
por: Kim, Kabsun, et al.
Publicado: (2022)

MicroRNA-26a Regulates RANKL-Induced Osteoclast Formation
por: Kim, Kabsun, et al.
Publicado: (2015)

Regulation of NFATc1 in Osteoclast Differentiation
por: Kim, Jung Ha, et al.
Publicado: (2014)

Spatiotemporal expression of RCAN1 and its isoform RCAN1-4 in the mouse hippocampus after pilocarpine-induced status epilepticus
por: Cho, Kyung-Ok, et al.
Publicado: (2020)

LIM Homeobox Transcription Factor 1-β Expression is Upregulated in Patients with Osteolysis after Total Ankle Arthroplasty and Inhibits Receptor Activator of Nuclear Factor-κB Ligand-Induced Osteoclast Differentiation in Vitro
por: Kim, Kabsun, et al.
Publicado: (2022)

Kruppel-like factor 4 attenuates osteoblast formation, function, and cross talk with osteoclasts
por: Kim, Jung Ha, et al.
Publicado: (2014)

Ginsenoside Rg2 inhibits osteoclastogenesis by downregulating the NFATc1, c-Fos, and MAPK pathways
por: Lee, Sung-Hoon, et al.
Publicado: (2023)

Rcan1 negatively regulates FcεRI-mediated signaling and mast cell function
por: Yang, Yong Jun, et al.
Publicado: (2009)

Anti-osteoclastogenic activity of matairesinol via suppression of p38/ERK-NFATc1 signaling axis
por: Choi, Sik-Won, et al.
Publicado: (2014)

Histone Deacetylase 3 Promotes RCAN1 Stability and Nuclear Translocation
por: Han, Kyung Ah, et al.
Publicado: (2014)

GATA4 negatively regulates osteoblast differentiation by downregulation of Runx2
por: Song, Insun, et al.
Publicado: (2014)

Cynanchi atrati and Its Phenolic Constituent Sinapic Acid Target Regulator of Calcineurin 1 (RCAN1) to Control Skin Inflammation
por: Kim, Seon Sook, et al.
Publicado: (2022)

Design of a RANK-Mimetic Peptide Inhibitor of Osteoclastogenesis with Enhanced RANKL-Binding Affinity
por: Hur, Jeonghwan, et al.
Publicado: (2016)

Dehydrocostus lactone inhibits NFATc1 via regulation of IKK, JNK, and Nrf2, thereby attenuating osteoclastogenesis
por: Lee, Hye In, et al.
Publicado: (2020)

Regulator of Calcineurin (RCAN): Beyond Down Syndrome Critical Region
por: Lee, Sun-Kyung, et al.
Publicado: (2020)

Anti-Osteoclastogenic Activity of Praeruptorin A via Inhibition of p38/Akt-c-Fos-NFATc1 Signaling and PLCγ-Independent Ca(2+) Oscillation
por: Yeon, Jeong-Tae, et al.
Publicado: (2014)

Leucine-Rich Repeat Kinase 2 (LRRK2) Stimulates IL-1β-Mediated Inflammatory Signaling through Phosphorylation of RCAN1
por: Han, Kyung A., et al.
Publicado: (2017)

Gα12 regulates osteoclastogenesis by modulating NFATc1 expression
por: Song, Min‐Kyoung, et al.
Publicado: (2017)

Upregulation of Ets1 expression by NFATc2 and NFKB1/RELA promotes breast cancer cell invasiveness
por: Kim, Gi-Cheon, et al.
Publicado: (2018)

Signaling Pathways in Osteoclast Differentiation
por: Kim, Jung Ha, et al.
Publicado: (2016)

Bone Cell Communication Factors Provide a New Therapeutic Strategy for Osteoporosis
por: Kim, Jung Ha, et al.
Publicado: (2020)

Betulin Suppresses Osteoclast Formation via Down-Regulating NFATc1
por: Kim, Kwang-Jin, et al.
Publicado: (2018)

NFATc1 regulates the transcription of DNA damage-induced apoptosis suppressor
por: Im, Joo-Young, et al.
Publicado: (2015)

Covalent NEDD8 Conjugation Increases RCAN1 Protein Stability and Potentiates Its Inhibitory Action on Calcineurin
por: Noh, Eun Hye, et al.
Publicado: (2012)

A major role for RCAN1 in atherosclerosis progression
por: Méndez-Barbero, Nerea, et al.
Publicado: (2013)

Rosiglitazone suppresses RANKL‐induced NFATc1 autoamplification by disrupting the physical interaction between NFATc1 and PPARγ
por: Park, Kyeong‐Lok, et al.
Publicado: (2018)

DGG-100629 inhibits lung cancer growth by suppressing the NFATc1/DDIAS/STAT3 pathway
por: Im, Joo-Young, et al.
Publicado: (2021)

GATA4 negatively regulates bone sialoprotein expression in osteoblasts
por: Song, Insun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_58n4c5bmgmt0iulqj5hubf3c1s